Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-098341
Filing Date
2016-02-12
Accepted
2016-02-12 20:55:12
Documents
1
Period of Report
2016-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3930
  Complete submission text file 0001209191-16-098341.txt   5298
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1500 WEST PARK DRIVE, SUITE 210 WESTBOROUGH MA 01581
Business Address
Dorman H. Paul (Reporting) CIK: 0001575028 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36304 | Film No.: 161422280